|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 1/14 | |
| C07K 1/34 | |||
| C07K 1/36 | |||
| C07K 16/30 |
| (11) | Number of the document | 3172220 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15750191.7 |
| Date of filing the European patent application | 2015-07-27 | |
| (97) | Date of publication of the European application | 2017-05-31 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/042241 |
| Date | 2015-07-27 |
| (87) | Number | WO 2016/015048 |
| Date | 2016-01-28 |
| (30) | Number | Date | Country code |
| 201462028994 P | 2014-07-25 | US |
| (72) |
MEH, David, US
ATOLAGBE, Timothy, US
FARQUHARSON, G. Mark, US
SHABAN, Samir, US
KOLECK, Mary, US
MITRA, George, US
|
| (73) |
United Therapeutics Corporation,
1040 Spring Street, Silver Spring, MD 20910,
US
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20892-7660, US |
| (54) | METHOD FOR PURIFYING ANTIBODIES |
| METHOD FOR PURIFYING ANTIBODIES |